EMEA-000878-PIP02-11

Key facts

Invented name
BindRen
Active substance
colestilan
Therapeutic area
Uro-nephrology
Decision number
P/207/2011
PIP number
EMEA-000878-PIP02-11
Pharmaceutical form(s)
  • Granules
  • Film-coated tablet
Condition(s) / indication(s)
Treatment of hyperphosphataemia
Route(s) of administration
Oral use
Contact for public enquiries
Mitsubishi Pharma Europe Ltd 
United Kingdom
E-mail: jvlek@m-pharma.co.uk
+44 (0)20 7065 5000
+44 (0)20 7065 5050
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating